Understanding the 2025 Medicare Part D Re-design: What You Need to Know
Innovaare Compliance
JANUARY 15, 2024
These changes mark a pivotal shift from its original structure in 2006. 6] A compound drug not approved by the FDA under a New Drug Application or Biological License Application does not meet the definition of an applicable drug and will not be eligible for Part D. Rebates from the selected drugs may change.
Let's personalize your content